Strides Of India, Pfizer Add 38 Cancer Drugs To Generic Partnership
This article was originally published in PharmAsia News
Executive Summary
India's Strides Arcolab has signed a licensing and supply agreement with U.S.-based Pfizer to continue their partnership for generic versions of 38 cancer drugs